← Back to Patent Explorer
US4251506A Expired / Lapsed US ⏱️ 0.0 years remaining

Controlled-release compositions for administration of therapeutic agents to ruminants

Assignee: Commonwealth Scientific and Industrial Research Organisation
•
Filing: 1978-05-09
•
Granted: 1981-02-17
•
Expires: 1998-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A controlled release composition for administering active agents to ruminants, which when mixed with said active agent has a melting point in excess of 39 DEG C. and when inserted as a solid into the rumen of a ruminent, is capable of slowly disintegrating at the interface between said composition and ruminal fluid present in the rumen of said ruminant. The composition may be administered by means of a variable geometry capsule.

Inventors

  • 👤 Ralph H. Laby

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 20:21
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0068

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 157 words
In a controlled release composition for administering active agents to ruminants, comprising an effective amount of an active agent, up to about 50% by weight based on the total weight of the composition, in a matrix of a biologically acceptable water insoluble wax and a biologically acceptable surfactant; the improvement in said matrix comprising at least two surfactants having an HLB value of 8.5 or less, the HLB values of said surfactants differing by not more than 2 units thereby avoiding differential dissolution and non-uniform active agent release rate arising from the component with the higher HLB value diffusing faster than the component with the lower HLB value, said composition comprising the improved matrix having a melting point in excess of 39° C. and, when inserted as a solid into the rumen of a ruminant, having the property of controlled slow disintegration at the interface between said composition and ruminal fluid in the rumen of said ruminant.
Claim 2
Dependent Claim 157 words
In a controlled release composition for administering active agents to ruminants, comprising an effective amount of an active agent, up to about 50% by weight based on the total weight of the composition, in a matrix of a biologically acceptable water insoluble wax and a biologically acceptable surfactant; the improvement in said matrix comprising at least two surfactants having an HLB value of 8.5 or less, the HLB values of said surfactants differing by not more than 2 units thereby avoiding differential dissolution and non-uniform active agent release rate arising from the component with the higher HLB value diffusing faster than the component with the lower HLB value, said composition comprising the improved matrix having a melting point in excess of 39° C. and, when inserted as a solid into the rumen of a ruminant, having the property of controlled slow disintegration at the interface between said composition and ruminal fluid in the rumen of said ruminant.
Claim 3
Dependent Claim 25 words
A composition according to claim 1, wherein the composition is capable of disintegrating at a rate in the range from 0.01 cm/day to 0.3 cm/day.
Claim 4
Dependent Claim 33 words
A composition according to claim 1, wherein the composition is capable of imbibing moisture from said ruminal fluid to cause said composition to swell at the interface thereby rendering it susceptible to disintegration.
Claim 5
Dependent Claim 30 words
A composition according to claim 1, wherein said surfactants are selected from the group consisting of sorbitan monostearate, sorbitan mono-oleate and stearyl alcohol ethoxylated with 2 moles of ethylene oxide.
Claim 6
Dependent Claim 29 words
A composition according to claim 1 comprising about 80% by weight of sorbitan monostearate and about 20% by weight of stearyl alcohol ethoxylated with 2 moles of ethylene oxide.
Claim 7
Dependent Claim 24 words
A therapeutic composition according to claim 1 wherein the therapeutic composition contains no more than 12 to 15% by weight of the therapeutic agent.
Claim 8
Dependent Claim 31 words
A therapeutic composition according to claim 1, wherein said therapeutic composition comprises layers of the therapeutic composition interposed between layers of said controlled release composition containing little or no therapeutic agent.
Claim 9
Dependent Claim 13 words
A therapeutic composition according to claim 1, wherein the therapeutic agent is oxfendazole.
Claim 10
Dependent Claim 40 words
A method of treating ruminants with a therapeutic composition according to claim 1, which method comprises administering said therapeutic composition to ruminants in such a manner that the composition is not regurgitated until substantially all said therapeutic composition has disintegrated.

References Cited (Backward Citations)

US3056724A Cited
US4132753A Cited
US3535419A Cited
US3374146A Cited
US3670065A Cited
US3538215A Cited
AU449029B2 Cited
US3857933A Cited
US3926817A Cited
US3696189A Cited
US3655864A Cited
US3959493A Cited
AU470538B2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-02-17 1984-08-18 1985-02-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-02-17 1988-08-18 1989-02-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-02-17 1992-08-18 1993-02-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag